Chen GL, Guo Y, Liu X, Yang Y, et al. Biomarker-Stratified Phase II Trial of Trastuzumab Rezetecan in Advanced Salivary Gland Carcinoma Across Cohorts With High and Low Human Epidermal Growth Factor Receptor 2 Expression. J Clin Oncol 2026;44:2614-2624.
PMID: 42579830